During the past decade, Palo Alto Veterans Adm Med Ctr / Stanford Univ conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 5 clinical trials were completed, i.e. on average, 166.7% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Palo Alto Veterans Adm Med Ctr / Stanford Univ" #1 sponsor was "National Institute of Allergy and Infectious Diseases (NIAID)" with 8 trials, followed by "Sunovion" with 4 trials sponsored, "University of Southern California" with 3 trials sponsored, "University of Pittsburgh" with 2 trials sponsored and "Bristol-Myers Squibb" with 2 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Palo Alto Veterans Adm Med Ctr / Stanford Univ" #1 collaborator was "Bristol-Myers Squibb" with 4 trials as a collaborator, "National Institute on Aging (NIA)" with 4 trials as a collaborator, "Alzheimer's Therapeutic Research Institute" with 3 trials as a collaborator, "National Institute of Nursing Research (NINR)" with 2 trials as a collaborator and "Northern California Institute of Research and Education" with 2 trials as a collaborator. Other collaborators include 5 different institutions and companies that were collaborators in the rest 15 trials.

According to Clinical.Site data, the most researched conditions in "Palo Alto Veterans Adm Med Ctr / Stanford Univ" are "HIV Infections" (8 trials), "Alzheimer Disease" (2 trials), "Bipolar I Disorder" (2 trials), "Dementia" (2 trials) and "Alzheimer's Disease" (1 trials). Many other conditions were trialed in "Palo Alto Veterans Adm Med Ctr / Stanford Univ" in a lesser frequency.

Most popular intervention types in "Palo Alto Veterans Adm Med Ctr / Stanford Univ" are "Drug" (14 trials), "Behavioral" (1 trials), "Biological" (1 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Zidovudine" (6 trials), "Didanosine" (4 trials), "Lurasidone" (4 trials), "Placebo" (2 trials) and "Adenosine" (1 trials). Other intervention names were less common.

The vast majority of trials in "Palo Alto Veterans Adm Med Ctr / Stanford Univ" are 19 trials for "All" genders.

Currently, there are NaN active trials in "Palo Alto Veterans Adm Med Ctr / Stanford Univ". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 16 completed trials in Palo Alto Veterans Adm Med Ctr / Stanford Univ, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Palo Alto Veterans Adm Med Ctr / Stanford Univ, 2 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".